Shengqing Li

1.8k total citations
76 papers, 1.1k citations indexed

About

Shengqing Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shengqing Li has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Shengqing Li's work include Pulmonary Hypertension Research and Treatments (11 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (5 papers). Shengqing Li is often cited by papers focused on Pulmonary Hypertension Research and Treatments (11 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (5 papers). Shengqing Li collaborates with scholars based in China, United States and South Korea. Shengqing Li's co-authors include Tongzuo Zhang, Zigang Dong, Ann M. Bode, Jingjie Zhang, Hongmei Gao, Zhenyuan Cai, Feng Jiang, Wen Qin, Ning Zhu and Guangying Li and has published in prestigious journals such as Journal of Biological Chemistry, The Science of The Total Environment and Cancer Research.

In The Last Decade

Shengqing Li

68 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengqing Li China 19 444 232 134 130 121 76 1.1k
James Denvir United States 22 774 1.7× 106 0.5× 12 0.1× 41 0.3× 286 2.4× 65 1.4k
Takashi Miyake Japan 24 452 1.0× 282 1.2× 10 0.1× 39 0.3× 112 0.9× 94 1.7k
Xuejing Wang China 19 536 1.2× 76 0.3× 8 0.1× 37 0.3× 168 1.4× 87 1.2k
Qinghua Zhang China 18 307 0.7× 67 0.3× 19 0.1× 51 0.4× 29 0.2× 64 788
Zhiying Zhang China 20 240 0.5× 83 0.4× 9 0.1× 27 0.2× 81 0.7× 79 1.2k
Yi Song China 23 874 2.0× 80 0.3× 6 0.0× 67 0.5× 91 0.8× 71 1.7k
Donald A. Primerano United States 19 570 1.3× 28 0.1× 12 0.1× 42 0.3× 123 1.0× 48 986
Ri‐Li Ge China 19 373 0.8× 199 0.9× 6 0.0× 78 0.6× 29 0.2× 86 1.2k
Xiaoya Li China 16 407 0.9× 38 0.2× 16 0.1× 26 0.2× 32 0.3× 49 842
F. Ferrara Italy 19 598 1.3× 46 0.2× 9 0.1× 215 1.7× 47 0.4× 84 1.3k

Countries citing papers authored by Shengqing Li

Since Specialization
Citations

This map shows the geographic impact of Shengqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengqing Li more than expected).

Fields of papers citing papers by Shengqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengqing Li. The network helps show where Shengqing Li may publish in the future.

Co-authorship network of co-authors of Shengqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shengqing Li. A scholar is included among the top collaborators of Shengqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengqing Li. Shengqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Biao‐Qi, Shengqing Li, Jianfei Xu, et al.. (2025). Preparation of hesperetin-polyvinylpyrrolidone sub-microparticles by supercritical anti-solvent technique for improved anti-cancer efficiency. The Journal of Supercritical Fluids. 219. 106523–106523. 3 indexed citations
2.
3.
4.
Huang, Ke, Junkoo Yi, Zhibin Liu, et al.. (2024). Effects of the major metal components in urban Asian PM2.5 on lung inflammation and abnormal electrolyte levels: an in vivo study based on review data. Environmental Pollutants and Bioavailability. 36(1). 1 indexed citations
5.
He, Weiwei, Hongbo Zhang, Xudong Lin, et al.. (2023). Advancements in life-on-a-chip: The impact of “Beyond Limits Manufacturing” technology. Chinese Chemical Letters. 35(5). 109091–109091. 2 indexed citations
6.
Zhou, Daibing, et al.. (2023). Characteristics and Comparison of Rapidly Growing and Slowly Growing nontuberculous Mycobacterial Pulmonary Disease. International Journal of Mycobacteriology. 12(3). 324–331. 2 indexed citations
7.
Chen, Xiaoxi, Qing Gu, Changming Xiong, et al.. (2022). Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China. CHEST Journal. 163(6). 1531–1542. 8 indexed citations
8.
Zhang, Xiujuan, Yuanyuan Zhang, Kun Chen, et al.. (2022). Diagnostic efficiency and safety of rapidon‐siteevaluation combined withCT‐guidedtransthoracic core needle biopsy in suspected lung cancer patients. Cytopathology. 33(4). 439–444. 9 indexed citations
9.
Wang, Jing, Xiujuan Zhang, Ning Zhu, et al.. (2022). Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling. Thoracic Cancer. 13(21). 3042–3051. 3 indexed citations
10.
Li, Guoyin, Zewen Song, Changjing Wu, et al.. (2022). Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma. Journal of Translational Medicine. 20(1). 47–47. 13 indexed citations
11.
Wu, Dandan, Yan‐Ming Xu, Machteld N. Hylkema, et al.. (2020). Ubiquitin carboxyl-terminal hydrolase isozyme L1/UCHL1 suppresses epithelial–mesenchymal transition and is under-expressed in cadmium-transformed human bronchial epithelial cells. Cell Biology and Toxicology. 37(4). 497–513. 8 indexed citations
12.
Yang, Tingyuan, Jie Wang, Mengzhen Lai, et al.. (2020). Design, synthesis and biological evaluation of potent EGFR kinase inhibitors against 19D/T790M/C797S mutation. Bioorganic & Medicinal Chemistry Letters. 30(16). 127327–127327. 23 indexed citations
13.
Lu, Lu, et al.. (2018). A Case of COPD with Left Endobronchial Hamartoma by Bronchoscopic Intervention. Case Reports in Clinical Medicine. 7(11). 550–556. 1 indexed citations
14.
Dong, Liang, Jingwen Xia, Jing Zhang, et al.. (2018). Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report. BMC Pulmonary Medicine. 18(1). 13–13. 5 indexed citations
15.
Liu, Kangdong, Donghoon Yu, Yong‐Yeon Cho, et al.. (2013). Sunlight UV-Induced Skin Cancer Relies upon Activation of the p38α Signaling Pathway. Cancer Research. 73(7). 2181–2188. 53 indexed citations
16.
17.
Kim, Dong Joon, Shengqing Li, Kun Yeong Lee, et al.. (2012). Polycomb (PcG) Proteins, BMI1 and SUZ12, Regulate Arsenic-induced Cell Transformation. Journal of Biological Chemistry. 287(38). 31920–31928. 29 indexed citations
18.
Li, Shengqing, Ann M. Bode, Feng Zhu, et al.. (2011). TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling. Carcinogenesis. 32(5). 779–785. 49 indexed citations
19.
Ren, Xinling, Yan‐Ming Xu, Haijing Fu, et al.. (2009). Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu. Cancer Letters. 281(2). 134–143. 12 indexed citations
20.
Li, Shengqing, Haowen Qi, Changgui Wu, et al.. (2007). Comparative proteomic study of acute pulmonary embolism in a rat model. PROTEOMICS. 7(13). 2287–2299. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Denvir Breakdown of academic impact, for papers by Takashi Miyake Breakdown of academic impact, for papers by Xuejing Wang Breakdown of academic impact, for papers by Qinghua Zhang Breakdown of academic impact, for papers by Zhiying Zhang Breakdown of academic impact, for papers by Yi Song Breakdown of academic impact, for papers by Donald A. Primerano Breakdown of academic impact, for papers by Ri‐Li Ge Breakdown of academic impact, for papers by Xiaoya Li Breakdown of academic impact, for papers by F. Ferrara
Rankless by CCL
2026